Resistant Gram-Negative Bacteria: Focus on the Real-World Use of Novel Beta-Lactams in Children

Antimicrobial resistance in gram-negative bacteria (GNB) is associated with a significant risk for morbidity and mortality.^1-3 The CDC lists several antimicrobial-resistant GNB as public health threats, including carbapenem-resistant Enterobacterales (CRE) and multidrug-resistant (MDR) Pseudomonas aeruginosa.¹ Although infections caused by these pathogens have been linked